Sort   by:  
 Page size 
UnknownPPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations.
Not available
S-EPMC5072371 | biostudies-literature
UnknownGermline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.
Not available
S-EPMC4643629 | biostudies-literature
UnknownClinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.
Not available
S-EPMC7463007 | biostudies-literature
UnknownEvidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study.
Not available
S-EPMC4264456 | biostudies-literature
UnknownMyD88 and TLR4 Expression in Epithelial Ovarian Cancer.
Not available
S-EPMC5870793 | biostudies-literature
UnknownDose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.
Not available
S-EPMC5744673 | biostudies-literature
UnknownPrognostic gene expression signature for high-grade serous ovarian cancer.
Not available
S-EPMC7484370 | biostudies-literature
UnknownA combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.
Not available
S-EPMC8207534 | biostudies-literature
UnknownDevelopment and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).
Not available
S-EPMC7572656 | biostudies-literature
Sort   by:  
 Page size